Previous Close
$
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$93.1 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressin...
Community
- 0 posts discussing
0
Watchers
0
Visitors